Files in This Item:
|internalmedicine.55.6765.pdf||166.58 kB||Adobe PDF||View/Open|
|Title:||The long-term clinical course of chronic eosinophilic pneumonia|
Uozumi, Ryuji https://orcid.org/0000-0002-9546-9869 (unconfirmed)
|Author's alias:||魚住, 龍史|
|Keywords:||chronic eosinophilic pneumonia|
|Publisher:||Japanese Society of Internal Medicine|
|Journal title:||Internal Medicine|
|Abstract:||Objective The long-term clinical course and prognosis of patients with chronic eosinophilic pneumonia (CEP) including factors predictive of the relapse of CEP have not been fully investigated. The aim of the present study was to investigate these issues. Methods We retrospectively investigated the rate of relapse and prognosis in 73 patients diagnosed as having CEP. Results Systemic corticosteroid therapy was administered at a prednisolone dose of 29.4±7.6 mg/day. During a median follow-up period of 1, 939 days, 27 patients suffered from relapse of CEP. Two patients developed steroid-induced diabetes mellitus, and 1 patient developed pulmonary nontuberculous mycobacteriosis. Five patients died; however, none died of CEP. A history of smoking was the only independent negative risk factor for relapse of CEP [hazard ratio, 0.37 (0.14-0.98)]. Conclusion Patients with CEP frequently relapse. During the follow-up, metabolic and infectious complications under prolonged corticosteroid therapy are problematic. A history of smoking was a negative factor for predicting the risk of CEP relapse.|
|Rights:||© 2016 The Japanese Society of Internal Medicine.|
The Internal Medicine is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
|Appears in Collections:||Journal Articles |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.